689290-83-3

Upstream product

• 693773-64-7 methanesulfonic acid 2-[6-(4-cyano-phenyl)-naphthalen-2-yl]-ethyl ester 
• 765-38-8 (R)-(-)-2-methylpyrrolidine 
• 689290-87-7 2-[6-(4-cyanophenyl)-2-naphthyl]ethyl 4-methylbenzenesulfonate 
• 305798-03-2 2-(6-bromonaphthalen-2-yl)acetonitrile 
• 689290-84-4 2-bromo-6-(chloromethyl)naphthalene 
• 100751-63-1 (6-bromo-2-naphthy)methanol 
• 32721-06-5 2-(6-bromonaphthalen-2-yl)acetic acid 
• 33626-98-1 methyl 6-bromo-2-naphthoate 
• 689290-86-6 4-[6-(2-hydroxyethyl)-2-naphthyl]benzonitrile 
• 689290-85-5 2-(6-bromonaphthalen-2-yl)ethan-1-ol 

Downstream Products

• 689292-14-6 C₄H₆O₆*C₂₄H₂₄N₂ 

Relevant academic research and scientific papers

4-[6-(2-Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration

4-[6-(2-Tertiaryaminoethyl)naphthalen-2-yl]benzonitriles are conformationally constrained histamine H3 receptor antagonists with high potency and selectivity. The analogs were designed around a naphthalene core, with the goal of enhancing lipop

Bicyclic-substituted amines as histamine-3 receptor ligands

Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such comp